Citations

Mayo Clinic

Showing 10 of 108599 citations.

BEYOND MAXIMUM GRADE: A NOVEL, LONGITUDINAL TOXICITY OVER TIME (TOXT) ADVERSE EVENT ANALYSIS OF LENALIDOMIDE IN FOLLICULAR LYMPHOMA IN CALGB 50401 (ALLIANCE)
Thanarajasingam, Gita , Novotny, Paul J. , Nowakowski, Grzegorz S. , Flowers, Christopher R. , Blum, Kristie A. , Pitcher, Brandelyn N., Atherton, Pamela J. , Tan, Angelina D., Sloan, Jeff A. , Leonard, John P. , Dueck, Amylou C. , Witzig, Thomas E. , Habermann, Thomas M. , Bartlett, Nancy L. , Jung, Sin‐Ho

Hematological Oncology | June 7, 2017 | Volume: 35 | Issue: S2 | Pages: 213-215

10.1002/hon.2438_78 Get It

HOST GENETIC VARIATION IN THE TNF AND NF‐ĸB PATHWAYS AND PROGNOSIS IN MANTLE CELL LYMPHOMA: AN ANALYSIS OF 2 STUDIES
Wang, Y., Wang, S.S., Inwards, David J. , Rothman, Nathaniel , Wang, Yucai , Habermann, Thomas M. , Maurer, Matthew J. , Link, Brian K. , Feldman, Andrew L. , Witzig, Thomas E. , Cozen, Wendy , Morton, Lindsay M. , Chanock, Stephen Jacob , Slager, Susan L. , Cerhan, James R.

Hematological Oncology | June 7, 2017 | Volume: 35 | Issue: S2 | Pages: 151-152

10.1002/hon.2438_4 Get It

PRODUCT CHARACTERISTICS ASSOCIATED WITH IN VIVO EXPANSION OF ANTI‐CD19 CAR T CELLS IN PATIENTS TREATED WITH AXICABTAGENE CILOLEUCEL (AXI‐CEL)
Neelapu, Sattva S. , Rossi, John M. , Xue, Allen , Better, Marc, Zhang, X., Lekakis, Lazaros J. , Jacobson, Caron A. , Braunschweig, Ira , Oluwole, Olalekan O. , Timmerman, John M. , Navale, Lynn, Go, William Y., Wiezorek, Jeff, Bot, Adrian , Locke, Frederick L. , Ghobadi, Armin , Miklos, David B. , Siddiqi, Tanya , Lin, Yi , Reagan, Patrick Michael , Oluwole, Olalekan O

Hematological Oncology | June 7, 2017 | Volume: 35 | Issue: S2 | Pages: 262-263

10.1002/hon.2438_132 Get It

EXPRESSION OF LAG‐3 DEFINES EXHAUSTION OF INTRATUMORAL PD‐1+ T CELLS AND CORRELATES WITH POOR OUTCOME IN FOLLICULAR LYMPHOMA
Kim, Hui Ji , Price-Troska, Tammy, Jalali, Shahrzad , Novak, Anne J. , Ansell, Stephen M. , Yang, Zhi-Zhang , Villasboas, José C. , Price-Troska, Tammy

Hematological Oncology | June 7, 2017 | Volume: 35 | Issue: S2 | Pages: 260-261

10.1002/hon.2438_128 Get It

PRELIMINARY RESULTS FROM AN OPEN‐LABEL, PHASE II STUDY OF TIPIFARNIB IN RELAPSED OR REFRACTORY PERIPHERAL T‐CELL LYMPHOMA
Sokol, Lubomir , Jacobsen, Eric D. , Burrows, Francis , Melvin, C., Mishra, Vishnu S. , Scholz, Catherine, Witzig, Thomas E. , Sokol, Lubomir , Advani, Ranjana H. , Mondejar, Rufino , Piris, Miguel Á. , Gualberto, Antonio

Hematological Oncology | June 7, 2017 | Volume: 35 | Issue: S2 | Pages: 251-252

10.1002/hon.2438_115 Get It

PROGNOSTIC FACTORS AND IMPACT OF ETOPOSIDE IN ADULTS WITH SYSTEMIC ALK‐POSITIVE ANAPLASTIC LARGE‐CELL LYMPHOMA: A POOLED ANALYSIS OF SIX STUDIES
Nguyen, Dinh-Phong , Schmitz, Norbert , Lamant, Laurence , Weisenburger, Dennis D. , Ziepert, Marita , Bast, M., Tilly, H., Jaïs, Jean Philippe, Sibon, David , Suzuki, Ritsuro , Feldman, Andrew L. , Gressin, Rémy , Nakamura, Shôji , Maurer, Matthew J. , Armitage, Jamés O. , Vose, Julie M. , Savage, Kerry J.

Hematological Oncology | June 7, 2017 | Volume: 35 | Issue: S2 | Pages: 240-240

10.1002/hon.2438_103 Get It

INTEGRATED ANALYSIS: OUTCOMES OF IBRUTINIB‐TREATED PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LEUKEMIA (CLL/SLL) WITH HIGH‐RISK PROGNOSTIC FACTORS
Fraser, Graeme , Brown, Jennifer R. , Byrd, John C. , Dilhuydy, M.S., Jaeger, Ulrich, Moreno, Carol , Chanan‐Khan, A.A., Mahler, Michelle, Salman, Mariya, Cheng, Minghua , Londhe, Anil, Ninomoto, Joi , Howes, Angela, James, Danelle F. , Kipps, Thomas J. , Coutré, Steven , Barrientos, Jacqueline C. , Barr, Paul M. , O’Brien, Susan , Hillmen, Peter , Cramer, Paula , Stilgenbauer, Stephan , Hallek, Michael

Hematological Oncology | June 7, 2017 | Volume: 35 | Issue: S2 | Pages: 109-111

10.1002/hon.2437_99 Get It

THE 23‐GENE GENE EXPRESSION‐BASED ASSAY DOES NOT PREDICT INTERIM PET SCAN RESULTS AFTER ABVD IN ADVANCED STAGE CLASSICAL HODGKIN LYMPHOMA IN THE US INTERGROUP S0816 TRIAL
Li, H., Harvey, Yasmin , Chan, Fong Chun , Boyle, M., Straus, David J. , Sweetenham, John , Fanale, Michelle A. , Cook, James R. , Leonard, John P. , Friedberg, Jonathan W. , Gascoyne, Randy D. , Scott, David W. , Mottok, Anja , Evens, Andrew M. , Schöder, Heiko , Bartlett, Nancy L. , Barr, Paul M. , Hsi, Eric D. , Kahl, Brad S. , LeBlanc, Michael , Steidl, Christian , Rimsza, Lisa M. , Press, Oliver W.

Hematological Oncology | June 7, 2017 | Volume: 35 | Issue: S2 | Pages: 92-93

10.1002/hon.2437_81 Get It

SAFETY AND EFFICACY OF COMBINATION OF BRENTUXIMAB VEDOTIN AND NIVOLUMAB IN RELAPSED / REFRACTORY HODGKIN LYMPHOMA: a TRIAL OF THE ECOG‐ACRIN CANCER RESEARCH GROUP (E4412)
David, Kevin A. , Cohen, Jonathon B. , Roberston, M., Palmisano, N., Ambinder, Rich, Ansell, Stephen M. , Diefenbach, Catherine , Hong, Fangxin , Advani, Ranjana H. , Kahl, Brad S.

Hematological Oncology | June 7, 2017 | Volume: 35 | Issue: S2 | Pages: 84-85

10.1002/hon.2437_72 Get It